Coagulation Disorders in Acute Renal Failure and Anticoagulation during CAVH with Standard Heparin and with Low Molecular Weight Heparin

2015 ◽  
pp. 25-36 ◽  
Author(s):  
J. Schrader ◽  
F. Scheler
Keyword(s):  
Molecular Weight ◽  
Renal Failure ◽  
Acute Renal Failure ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
Coagulation Disorders

scholarly journals Retroperitoneal Haematoma Associated with Low Molecular Weight Heparin

2002 ◽  
Vol 30 (5) ◽  
pp. 665-667 ◽  
Author(s):  
G. E. Power ◽  
P. Rogers
Keyword(s):  
Molecular Weight ◽  
Renal Failure ◽  
Acute Renal Failure ◽  
Side Effects ◽  
Blood Transfusion ◽  
Low Molecular Weight Heparin ◽  
Inotropic Support ◽  
Low Molecular Weight ◽  
Retroperitoneal Haematoma

Enoxaparin (a low molecular weight heparin) has been used extensively for its antithrombotic properties. Complications of its haemorrhagic side-effects have previously been described. We report two cases of extensive retroperitoneal haematoma requiring blood transfusion and inotropic support. One patient developed acute renal failure and did not respond to intensive resuscitative efforts.

Retroperitoneal Hematoma Caused by Low-Molecular-Weight Heparin Retroperitoneal Hemorrhage Due to Warfarin Thromboembolism and Clozapine Therapy Neutropenia Caused by Valproic Acid Amoxicillin Crystalluria as a Cause of Acute Renal Failure Facial Hyperpigmentation Associated with Imipramine Readers Address Psychiatric Problems Related to Opiates

2003 ◽  
Vol 38 (8) ◽  
pp. 729-733
Author(s):  
Joel Shuster
Keyword(s):  
Molecular Weight ◽  
Valproic Acid ◽  
Renal Failure ◽  
Acute Renal Failure ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
Drug Reactions ◽  
Retroperitoneal Hemorrhage ◽  
Clozapine Therapy ◽  
Psychiatric Problems

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.

scholarly journals Low-Molecular-Weight Heparin and Lipoprotein(a) in Patients with Chronic Renal Failure

Nephron ◽  
1997 ◽  
Vol 76 (1) ◽  
pp. 123-124 ◽  
Author(s):  
Andrea Sagripanti ◽  
Vincenzo Cozza ◽  
Giuliano Barsotti
Keyword(s):  
Molecular Weight ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
Lipoprotein A

Pharmacokinetics of a Low Molecular Weight Heparin (Fraxiparine®) in Various Stages of Chronic Renal Failure

Nephron ◽  
1991 ◽  
Vol 59 (4) ◽  
pp. 543-545 ◽  
Author(s):  
C. Goudable ◽  
S. Saivin ◽  
G. Houin ◽  
P. Sie ◽  
B. Boneu ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight

COMPLICATION OF OLIGURIC ACUTE RENAL FAILURE IN PATIENTS TREATED WITH LOW-MOLECULAR WEIGHT DEXTRAN

Renal Failure ◽  
2001 ◽  
Vol 23 (5) ◽  
pp. 679-684 ◽  
Author(s):  
Akihiko Kato ◽  
Katsuhiko Yonemura ◽  
Hideki Matsushima ◽  
Naoki Ikegaya ◽  
Akira Hishida
Keyword(s):  
Molecular Weight ◽  
Renal Failure ◽  
Acute Renal Failure ◽  
Low Molecular Weight ◽  
Oliguric Acute Renal Failure
Sign in / Sign up

Export Citation Format

Share Document